Search

1. Searching for savings in Medicare drug price negotiations

Author(s):

Cubanski, Juliette, author
Neuman, Tricia, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, April 2018

Subject(s):

Drug Costs
Medicare Part D -- economics
Negotiating
Prescription Drugs -- economics
United States

2. What's in the administration's 5-part plan for Medicare Part D and what would it mean for beneficiaries and program savings?

Author(s):

Cubanski, Juliette, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, June 2018

Subject(s):

Cost Savings
Medicare Part D -- economics
United States

3. Medicare Part D: a first look at prescription drug plans in 2019

Author(s):

Cubanski, Juliette, author
Damico, Anthony, author
Neuman, Tricia, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, October 2018

Subject(s):

Medicare Part D -- economics
Medicare Part D -- statistics & numerical data
United States

4. Medicare's income-related premiums under current law and changes for 2019

Author(s):

Cubanski, Juliette, author
Neuman, Tricia, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, October 2018

Subject(s):

Fees and Charges
Income
Medicare Part B -- economics
Medicare Part D -- economics
United States

5. Summary of recent and proposed changes to Medicare prescription drug coverage and reimbursement

Author(s):

Cubanski, Juliette, author

Publication:

Menlo Park, CA : Henry J. Kaiser Family Foundation, February 2018

Subject(s):

Medicare Part B -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
United States

6. Increases in reimbursement for brand-name drugs in Part D

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018

Subject(s):

Drug Costs -- trends
Drug Utilization -- trends
Insurance, Health, Reimbursement
Medicare Part D -- economics
United States
United States. Department of Health and Human Services

7. Questionable billing for compounded topical drugs in Medicare Part D

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2018

Subject(s):

Dermatologic Agents -- economics
Dermatologic Agents -- therapeutic use
Drug Compounding -- economics
Drug Utilization -- trends
Fraud
Insurance, Health, Reimbursement
Medicare Part D -- economics
Skin Cream -- economics
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

8. Prescription drugs: Department of Veterans Affairs paid about half as much as Medicare Part D for selected drugs in 2017 : report to the Ranking Member, Committee on the Budget, U.S. Senate

Publication:

Washington, DC : United States Government Accountability Office, December 2020

Subject(s):

Costs and Cost Analysis -- statistics & numerical data
Drug Costs -- statistics & numerical data
Government Regulation
Medicare Part D -- economics
United States
United States. Department of Veterans Affairs

9. Prescription drugs: U.S. prices for selected brand drugs were higher on average than prices in Australia, Canada, and France : report to the Chairman, Committee on the Budget, U.S. Senate

Publication:

Washington, DC : United States Government Accountability Office, March 2021

Subject(s):

Costs and Cost Analysis
Government Regulation
Medicare Part D -- economics
Prescription Drugs -- economics
United States

10. Drug price increases that exceed inflation are costing Medicare Part D billions

Author(s):

Purvis, Leigh, author

Publication:

Washington, DC : AARP Public Policy Institute, June 2021

Subject(s):

Drug Costs
Inflation, Economic
Medicare Part D -- economics
Medicare Part D -- trends
Prescription Drugs -- economics
United States